Michael S Perry sold $1.0M of Arrowhead Pharmaceuticals (ARWR)

Executed Aug 18, disclosed Aug 20, 2 days later.

Value, as filed

$1.0M

11,600 sh × $87.30

Executed

Aug 18

the trade date, as filed

Disclosed

Aug 20

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael S Perry Director profile →

Michael S Perry (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $1.0M of ARWR (11,600 sh × $87.30, as filed), executed Aug 18.

The name

ARWR

Arrowhead Pharmaceuticals, Inc. ARWR · Healthcare · 34 filings in 24 months ticker →

Healthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael S Perry in ARWR

ARWRSALE Arrowhead Pharmaceuticals, Inc. $992K
16,250 sh × $61.03
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET